Reinvestigation into the synthesis of oligonucleotides containing 5-(β-D-glucopyranosyloxymethyl)-2′-deoxyuridine

European Journal of Organic Chemistry

Volumn , Issue 19, 2003, Pages 3832-3839

  Turner, John J ^a   Meeuwenoord, Nico J ^a   Rood, Anita ^a   Borst, Piet ^b   Van der Marel, Gijs A ^a   Van Boom, Jacques H ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Ammonolysis; Decomposition; Modified nucleobase; Nucleosides; Oligonucleotides

Indexed keywords

5 (AMINOMETHYL) 2' DEOXYURIDYL DERIVATIVE; 5 (BETA DEXTRO GLUCOPYRANOSYLOXYMETHYL) 2' DEOXYURIDINE; AMMONIA; DEOXYGLUCOSE; DEOXYURIDINE DERIVATIVE; DNA FRAGMENT; OLIGONUCLEOTIDE; PHOSPHORAMIDIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VARIANT SURFACE GLYCOPROTEIN;

AMMONIOLYSIS; ANTIGENIC VARIATION; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DECOMPOSITION; DEPROTECTION REACTION; DNA SEQUENCE; DNA SYNTHESIS; LYSIS; MASS SPECTROMETRY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE; SOLID; TRYPANOSOMA BRUCEI;

EID: 0141891469     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200300218     Document Type: Article

References (23)

1. P. Borst, Immunology Today 1991, 12, A29.
2. J. D. Barry, Parasitol. Today 1997, 13, 212-218.
3. P. Borst, G. Rudenko, M. C. Taylor, P. A. Blundell, F. van Leeuwen, W. Bitter, M. Cross, R. McCulloch, Arch. Med. Res. 1996, 27, 379-388.
4. G. A. M. Cross, BioEssays 1996, 18, 283-291.
5. A. Bernards, Nucleic Acids Res. 1984, 12, 4153-4170.
6. E. Pays, M. F. Delauw, M. Laurent, M. Steinert, Nucleic Acids Res. 1984, 12, 5235-5247.
7. F. van Leeuwen, E. R. Wijsman, R. Kieft, G. A. van der Marel, J. H. van Boom, P. Borst, Genes Dev. 1997, 11, 3232-3241.
8. F. van Leeuwen, R. Kieft, M. Cross, P. Borst, Mol. Cell. Biol. 1998, 18, 5643-5651.
9. F. van Leeuwen, M. C. Taylor, A. Mondragon, H. Moreau, W. Gibson, R. Kieft, P. Borst, Proc. Natl. Acad. Sci. USA 1998, 95, 2366-2371.
10. M. Cross, R. Kieft, R. Sabatini, M. Wilm, M. de Kort, G. A. van der Marel, J. H. van Boom, F. van Leeuwen, P. Borst, EMBO 1999, 18, 6573-6581.
11. R. Sabatini, N. Meeuwenoord, J. H. van Boom, P. Borst, J. Biol. Chem. 2002, 277, 958-966.
12. R. Sabatini, N. Meeuwenoord, J. H. van Boom, P. Borst, J. Biol. Chem. 2002, 277, 28150-28156.
13. E. R. Wijsman, O. van den Berg, E. Kuyl-Yeheskiely, G. A. van der Marel, J. H. van Boom, Recl. Trav. Chim. Pays-Bas 1994, 113, 337-338.
14. M. de Kort, E. Ebrahimi, E. R. Wijsman, G. A. van der Marel, J. H. van Boom, Eur. J. Org. Chem. 1999, 2337-2344.
15. J. M. Brown, C. Cristodoulou, S. S. Jones, A. S. Modak, C. B. Reese, S. Sibanda, A. Ubusawa, J. Chem. Soc., Perkin Trans. 1 1989, 1735-1753.
16. It should be noted that a higher-resolution ion-exchange column than previously was used (Dionex-Pac). In addition, the buffer was changed from pH 12 to pH 7 in order better to visualise and quantify the side product 15, which at pH 12 is a shoulder on the right hand side of the main peak (14).
17. No protection of the 2-deoxyribose moiety hydroxy groups was used, as these are not responsible for decomposition and leaving them unmasked aids solubility in the aqueous medium.
18. G. T. Shiau, R. F. Schinazi, M. S. Chen, W. H. Prusoff, J. Med. Chem. 1980, 23, 127-133.
19. 3N· 3HF, py, room temp., 16 h
20. Use of the more labile methoxyacetyl hydroxy group protection would provide no further advantage, as TAC protection requires 2 h for complete removal.
21. M. de Kort, P. C. de Visser, J. Kurzeck, N. J. Meeuwenoord, G. A. van der Marel, W. Ruger,. J. H. van Boom, Eur. J. Org. Chem. 2001, 2075-2082.
22. B. T. Gillis, J. Org. Chem. 1959, 24, 1027-1029.
23. N. D. Sinha, J. Biernat, J. McManus, H. Köster, Nucleic Acids Res. 1984, 12, 4051-4061.